SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-277147
Filing Date
2023-11-14
Accepted
2023-11-14 16:31:56
Documents
14
Period of Report
2023-11-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d416540d8k.htm   iXBRL 8-K 28914
2 EX-10.1 d416540dex101.htm EX-10.1 69757
3 EX-10.2 d416540dex102.htm EX-10.2 69898
  Complete submission text file 0001193125-23-277147.txt   341107

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA krro-20231108.xsd EX-101.SCH 2851
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE krro-20231108_lab.xml EX-101.LAB 19501
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krro-20231108_pre.xml EX-101.PRE 12157
8 EXTRACTED XBRL INSTANCE DOCUMENT d416540d8k_htm.xml XML 3643
Mailing Address ONE KENDALL SQUARE. BUILDING 600-700 SUITE 6-401 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE. BUILDING 600-700 SUITE 6-401 CAMBRIDGE MA 02139 617-468-1900
Korro Bio, Inc. (Filer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39062 | Film No.: 231407069
SIC: 2834 Pharmaceutical Preparations